The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application, identified as TM99332815, for the mark MITOFLEX. This application pertains to electronic light therapy apparatus designed for various therapeutic purposes, including relief from stiffness, enhancement of local blood circulation, support for cellular function, relaxation, and promotion of mitochondrial energy production. The filing date for this application was August 12, 2025, with an intent to use date of March 24, 2026.

This filing represents a new trademark application for a medical device. While this is not a regulatory rule or enforcement action, it is relevant for manufacturers and legal professionals involved in the medical device sector, particularly those dealing with intellectual property and product classification. Compliance officers should note this as an indicator of market activity and potential future product launches in the light therapy space.